Month: August 2023

Oslo, Norway – 30 August 2023 – IDEX Biometrics has successfully completed the full Mastercard certification and received Conformity Compliance Statement (CCS) for its IDEX Biometrics Payment Card solution1. The complete and certified biometric card solution includes the IDEX biometric sensor, a Linxens EMV2 module including Infineon’s SLC38B secure element, card inlay with antenna, and the IDEX card operating system with payment applets. Biometric payment cards built on the IDEX Biometrics payment card solution will provide seamless payment experiences for consumers around the world. The IDEX Biometrics payment card solution has successfully completed Mastercard’s Compliance Assessment and Security Testing (CAST). This is the final Mastercard certification step and follows the previously announced FTAS certification of the sensor performance....

SB Asset Management, a company established by Šiaulių bankas, has been granted by the Bank of Lithuania a license of a management company acting in accordance with the Law on Collective Investment Undertakings of the Republic of Lithuania. SB Asset Management has been established in preparation for the implementation regarding the merger of Šiaulių bankas and Invalda INVL retail client asset management and life insurance businesses with Šiaulių bankas (see. Notice). It is estimated that after the transaction closing date the SB Asset Management would take over the management business of pension funds and investment funds for its further development. ”This license is an important achievement for implementation  of the transaction with Invalda INVL, allowing the merger to proceed as planned. We believe that the development of savings and...

Aspocomp Group Plc, Inside Information, August 30, 2023, at 8:45 a.m. Aspocomp’s change negotiations at its Oulu plant have ended. The goal of the negotiations was to prepare for a partial adjustment of production to correspond to temporarily low delivery volumes. As a result of the change negotiations, the company’s plan is to lay off 20-30 production blue-collar employees at a time for a maximum of 90 days during the next six months. For the first three months, 26 people will be temporarily laid off. At the start of the negotiations, the company estimated that the adaptation measures would lead to layoffs for a maximum of 90 days, and most of the Oulu plant’s approximately 120 production blue-collar employees were covered by the negotiations. Slower-than-expected recovery of the semiconductor cycle and high inventory levels in...

Company announcement – No. 31 / 2023 Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinismUS FDA has granted priority review designation to dasiglucagon for the prevention and treatment of hypoglycemia in pediatric patients 7 days of age and older with congenital hyperinsulinism (CHI) for up to 3 weeks of dosing with a Prescription Drug User Fee Act (PDUFA) date on December 30, 2023. To ensure the most efficient regulatory process, the review by the US FDA will be conducted in two parts under the same New Drug Application (NDA). Part 1 relates to dosing for up to 3 weeks, whereas Part 2 relates to use beyond 3 weeks. The PDUFA date for Part 2 will be set following submission of additional analyses from existing datasets requested by the US FDA, which is expected before the...

OSLO, Norway (30 August 2023) – TGS, the leading global provider of energy data and intelligence, today reported a pending award for multiple proprietary Ocean Bottom Node (OBN) projects in the Gulf of Mexico (GoM). The projects will be acquired over a 3-year duration. The negotiations and scope will be finalized during Q3 2023, with the initial project targeted to mobilize in late Q1 2024. Kristian Johansen, CEO at TGS, commented: “This progress and endeavour towards confirming a long-term commitment from a major producer in the Gulf of Mexico and strategic customer reflects our unwavering commitment to innovation and excellence and highlights our ability to adapt to evolving industry needs worldwide. Through our continued focus, service quality and commitment to operating safely and sustainably, we will continue to support the...

In cooperation with 1Partner Advisory (1PA), Enlight Research published equity research on EfTEN Real Estate Fund AS (EfTEN; EFT1T). The report is attached to the release and can be downloaded on the Enlight Research and EfTEN Real Estate Fund AS websites. In the future, Enlight Research/1PA aims to publish two reports per year on EfTEN. Kristjan Tamla, CEO, EfTEN Capital AS, ”It is a great honor that the most professional equity research house in the Baltics has initiated the coverage of the EfTEN Real Estate Fund AS. Enlight Research reports are highly appreciated by local as well as by international investor communities. It is encouraging to see that robustness of the EfTEN portfolio and EfTEN’s strategy of maintaining low leverage is now also validated by an independent third-party analysis. The Base case Fair value of 21.84 EUR per...